| Market Size 2023 (Base Year) | USD 2.02 Billion |
| Market Size 2032 (Forecast Year) | USD 3.52 Billion |
| CAGR | 5.7% |
| Forecast Period | 2024 - 2032 |
| Historical Period | 2018 - 2023 |
According to Market Research Store, the global pharmaceutical grade hemp oil market size was valued at around USD 2.02 billion in 2023 and is estimated to reach USD 3.52 billion by 2032, to register a CAGR of approximately 5.7% in terms of revenue during the forecast period 2024-2032.
The pharmaceutical grade hemp oil report provides a comprehensive analysis of the market, including its size, share, growth trends, revenue details, and other crucial information regarding the target market. It also covers the drivers, restraints, opportunities, and challenges till 2032.

To Get more Insights, Request a Free Sample
Pharmaceutical grade hemp oil is a highly refined extract derived from the hemp plant (Cannabis sativa) that meets stringent quality and purity standards required for medical and therapeutic applications. Unlike standard hemp oil, which may contain varying levels of cannabinoids and impurities, pharmaceutical grade hemp oil undergoes rigorous processing, third-party testing, and regulatory compliance to ensure it is free from contaminants such as heavy metals, pesticides, and residual solvents. This oil is rich in beneficial cannabinoids, primarily cannabidiol (CBD), with precise concentrations tailored for use in pharmaceuticals, nutraceuticals, and clinical research. It is commonly utilized in formulations for pain relief, anxiety management, epilepsy treatment, and other medical conditions, often under the supervision of healthcare professionals.
Key Growth Drivers
Restraints
Opportunities
Challenges
| Report Attributes | Report Details |
|---|---|
| Report Name | Pharmaceutical Grade Hemp Oil Market |
| Market Size in 2023 | USD 2.02 Billion |
| Market Forecast in 2032 | USD 3.52 Billion |
| Growth Rate | CAGR of 5.7% |
| Number of Pages | 140 |
| Key Companies Covered | ENDOCA, BAFA Gmbh, Protect Pharma Rakitovica, Biobloom Hemp, Deep Nature Project, Harmony, DragonflyCBD, MH medical hemp GmbH, Celtic Wind, HemPoland, Opencrop GmbH, Gaia Botanicals, Isodiol, Medical Marijuana, Canopy Growth, IRIE CBD, Elixinol, NuLeaf Naturals, PharmaHemp, Folium Biosciences |
| Segments Covered | By Product Type, By Application, and By Region |
| Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
| Base Year | 2023 |
| Historical Year | 2018 to 2023 |
| Forecast Year | 2024 to 2032 |
| Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The global pharmaceutical grade hemp oil market is divided by type, application, and region.
Based on type, the global pharmaceutical grade hemp oil market is divided into essential oil, cream, and other.
The most dominant segment in the pharmaceutical-grade hemp oil market by type is Essential Oil. Essential hemp oil is widely used in pharmaceuticals due to its high concentration of cannabinoids, particularly cannabidiol (CBD), which is known for its therapeutic properties. This segment is extensively utilized for pain management, anxiety relief, and neurological disorders, making it the preferred choice for both pharmaceutical manufacturers and consumers seeking natural alternatives to traditional medicine. The rising demand for CBD-based treatments and increasing regulatory approvals for medical cannabis further drive the growth of this segment.
The Cream segment follows as the second most dominant category. Hemp oil-infused creams are commonly used in dermatology and pain relief applications. These topical formulations are popular for treating conditions such as eczema, psoriasis, and muscle pain. Their non-invasive application and localized effects make them highly attractive to consumers who prefer external remedies over oral ingestion. Moreover, the growing awareness of hemp oil's anti-inflammatory and skin-nourishing benefits has contributed to the increasing adoption of pharmaceutical-grade hemp oil creams.
On the basis of application, the global pharmaceutical grade hemp oil market is bifurcated into skin health, natural pain relief, muscle tension, and others.
The most dominant segment in the pharmaceutical-grade hemp oil market by application is Skin Health. Hemp oil is widely used in dermatological treatments due to its rich content of essential fatty acids, antioxidants, and anti-inflammatory compounds. It is particularly effective in managing conditions like eczema, psoriasis, acne, and general skin hydration. The growing demand for natural skincare products, combined with the rising awareness of hemp oil’s benefits, has propelled this segment to the forefront. Pharmaceutical companies and cosmetic brands are increasingly incorporating hemp oil into skincare formulations, further driving market growth.
The Natural Pain Relief segment follows closely behind. Hemp oil’s analgesic and anti-inflammatory properties make it a popular choice for managing chronic pain conditions such as arthritis, migraines, and neuropathic pain. Many consumers prefer hemp oil-based treatments over traditional painkillers due to their perceived safety and minimal side effects. The increasing acceptance of cannabidiol (CBD) for medical use and ongoing research into its effectiveness in pain management contribute significantly to this segment’s expansion.
The Muscle Tension segment ranks third in dominance. Hemp oil is often used in muscle relaxation therapies, particularly among athletes and individuals suffering from muscle soreness or stiffness. It is incorporated into massage oils, balms, and creams to provide localized relief. The growing trend of fitness and wellness, along with the demand for natural recovery solutions, supports the growth of this segment.
North America maintains its leading position in the pharmaceutical-grade hemp oil market, with the United States at the forefront. The legalization of hemp cultivation has significantly boosted production capabilities, fostering a robust supply chain for hemp-derived products. Consumer awareness regarding the therapeutic benefits of hemp oil, especially cannabidiol (CBD), has surged, leading to its widespread adoption in managing conditions like chronic pain and anxiety. The presence of major industry players investing heavily in research and development further solidifies North America's dominant position in this market.
Europe emerges as a significant contender in the pharmaceutical-grade hemp oil sector, with countries such as Germany, the United Kingdom, and France at the forefront. The European Union's efforts to harmonize regulations surrounding hemp cultivation and product distribution have facilitated smoother market operations across member states. A growing consumer shift towards natural and organic health solutions has amplified the demand for hemp oil, particularly in the cosmetics and personal care industries. Additionally, Europe's emphasis on sustainability aligns with the eco-friendly nature of hemp cultivation, further propelling market growth in the region.
The Asia-Pacific region is experiencing rapid growth in the pharmaceutical-grade hemp oil market, with China and India leading the charge. In China, government initiatives promoting hemp cultivation as part of agricultural development have resulted in significant investments in hemp-based product research and manufacturing. India is witnessing increased acceptance of hemp oil, particularly in wellness and dietary supplements, driven by a burgeoning health-conscious population. The region's expanding beauty and personal care industry is also incorporating hemp oil for its nutritional benefits and sustainability, positioning Asia-Pacific as a burgeoning market for pharmaceutical-grade hemp oil.
Latin America holds a modest yet growing share in the pharmaceutical-grade hemp oil market. Countries like Brazil and Argentina are gradually embracing hemp-derived products, influenced by changing regulations and increasing awareness of their therapeutic benefits. The region's rich agricultural landscape offers potential for hemp cultivation, which could bolster local production and reduce reliance on imports. However, market expansion is tempered by regulatory challenges and limited consumer awareness, necessitating concerted efforts in education and policy reform to unlock Latin America's full market potential.
The Middle East and Africa represent the nascent stages of the pharmaceutical-grade hemp oil market. Recent regulatory changes in certain African nations have begun to permit hemp cultivation for medicinal purposes, signaling a slow yet positive shift towards market acceptance. The region's developing healthcare infrastructure and growing interest in alternative medicines present opportunities for future growth. Nonetheless, cultural perceptions and stringent regulations in various countries pose significant challenges, requiring strategic navigation to foster market development in these regions.
The report provides an in-depth analysis of companies operating in the pharmaceutical grade hemp oil market, including their geographic presence, business strategies, product offerings, market share, and recent developments. This analysis helps to understand market competition.
Some of the major players in the global pharmaceutical grade hemp oil market include:
The global pharmaceutical grade hemp oil market is segmented as follows:
By Type
By Application
By Region
Based on statistics from the Market Research Store, the global pharmaceutical grade hemp oil market size was projected at approximately US$ 2.02 billion in 2023. Projections indicate that the market is expected to reach around US$ 3.52 billion in revenue by 2032.
The global pharmaceutical grade hemp oil market is expected to grow at a Compound Annual Growth Rate (CAGR) of around 5.7% during the forecast period from 2024 to 2032.
North America is expected to dominate the global pharmaceutical grade hemp oil market.
The global pharmaceutical-grade hemp oil market is driven by increasing consumer awareness of its therapeutic benefits, expanding legalization of hemp-derived products, and rising demand for natural and organic healthcare solutions. Additionally, advancements in extraction technologies and growing applications in pharmaceuticals, cosmetics, and nutraceuticals further boost market growth.
Some of the prominent players operating in the global pharmaceutical grade hemp oil market are; ENDOCA, BAFA Gmbh, Protect Pharma Rakitovica, Biobloom Hemp, Deep Nature Project, Harmony, DragonflyCBD, MH medical hemp GmbH, Celtic Wind, HemPoland, Opencrop GmbH, Gaia Botanicals, Isodiol, Medical Marijuana, Canopy Growth, IRIE CBD, Elixinol, NuLeaf Naturals, PharmaHemp, Folium Biosciences, and others.
Pharmaceutical Grade Hemp Oil
Pharmaceutical Grade Hemp Oil
×